Table 5.
Follow-up | Outcomes |
---|---|
Mean follow-up, months (range) | 26.1 ± 10.1 (2–39 months) |
Endoleak, n (%) | |
Type I | 2 (9) |
Type IV | 1 (5) |
Primary target vessel patency (%) | 92 |
Secondary target vessel patency (%) | 96 |
Death caused by, n (%) | |
Myocardial infarction | 2 (9) |
Aneurysm rupture for Type I endoleak | 1 (5) |